Sun Pharmaceutical Industries Share Price Target 2025, 2026, 2027, 2028, 2029, 2030, 2040 upto 2050

Sun Pharmaceutical Industries Share Price Target

Table of Contents

WhatsApp Group Join Now

Telegram Group Join Now

Here are the projected share price target for Sun Pharmaceutical Industries Ltd. for 2025, 2026, 2027, 2028, 2029, 2030, 2040, to 2050 based on various analyses.

Year	Target 1	Target 2
2025	₹2408	₹2606
2026	₹3092	₹3388
2027	₹3776	₹4170
2028	₹4460	₹4952
2029	₹5144	₹5734
2030	₹5828	₹6516
2040	₹9800	₹11656
2050	₹19732	₹23124

Sun Pharmaceutical Industries Share Price Target 2025 : Analysts predict potential Targets of ₹2,408, ₹2,606 by the end of 2024. The stop loss levels are set at ₹2167.8, ₹2345.4.

Sun Pharmaceutical Industries Share Price Target 2026 : Projections for 2026 suggests a minimum Target of ₹3,092 and a maximum of ₹3,388.

Sun Pharmaceutical Industries Share Price Target 2027 : The price target range from ₹3,776 to ₹4,170 depending on market conditions.

Sun Pharmaceutical Industries Share Price Target 2028 : At the start of 2028, the price is projected to be around ₹4,460 and by the end of the 2028, the price target is expected to reach approximately ₹4,952.

Sun Pharmaceutical Industries Share Price Target 2029 : The share price is expected to start the year around ₹5,344 and by the end of the year, the share price might reach approximately ₹5,734.

Sun Pharmaceutical Industries Share Price Target 2030 : Long term projections for 2030 range from ₹6,128 to ₹7,324 with an average target of ₹6,726.

Sun Pharmaceutical Industries Share Price Target 2040 : The stock could be potentially be in the range of ₹9,800 to ₹11,656 depending on the market conditions, inflation, and the company’s performance.

Sun Pharmaceutical Industries Share Price Target 2050 : With continued growth, the stock could theoretically reach ₹19,732 to ₹23,124 or more, but this is highly speculative and assumes that the company continues to perform well over long term.

For more detailed projections and updates, it is advisable to keep track of market reports and financial news.

About The Company

Sun Pharmaceutical Industries Share Price Target

Sun Pharmaceutical Industries Ltd. was founded by Dilip Shanghvi in 1993, is a leading Indian pharmaceutical company and a global leader in the generic drug market based in Mumbai, India. It offers a wide range of pharmaceutical products, including Tablets & capsules, Injectables, Inhalers, Ointments & creams and Liquids for a range of medical needs. Visit sunpharma.com for more info.

Fundamentals Of The Company

Market Cap	₹4,37,807 Cr
PE Ratio(TTM)	42.14
P/B Ratio	6.88
Industry P/E	39.46
Debt to Equity	0.05
ROCE	17.3%
ROE	15.04%
Div Yield	0.74%
Book Value	₹265.35
Face Value	1
EPS(TTM)	43.30

Market Cap : The market capitalization of Sun Pharmaceutical Industries Ltd. is ₹4,37,483 crore. This figure represents the total market value of the company’s outstanding shares and indicates its size and significance in the stock market.
P/E Ratio : The Price to Earning (P/E) Ratio for Sun Pharmaceutical Industries Ltd. based on trailing twelve months(TTM) data is 42.11. This ratio indicates how much investors are willing to pay per rupee of earnings, reflecting market expectations of the company’s future growth prospects.
P/B Ratio : The Price to Book Ratio for Sun Pharmaceutical Industries Ltd. is 6.87. This ratio compares the company’s market capitalization to its book value, providing insight into how much investors are willing to pay for each rupee of net assets.
Industry P/E : The Industry P/E Ratio is 39.56. This figure represents the average P/E Ratio for companies within the same industry, providing a benchmark for comparing Sun Pharmaceutical Industries Ltd.’s valuation to its peers.
Debt to Equity : The Debt to Equity for Sun Pharmaceutical Industries Ltd. is 0.05. This indicates that the company has relatively low levels of debt compared to its equity, suggesting a conservative approach to leveraging.
ROE : The Return on Equity for Sun Pharmaceutical Industries Ltd. is 15.04%. This metric measures the company,s profitability relative to shareholder’s equity, indicating how effectively it is using shareholder’s funds to generate profit.
EPS : The Earnings Per Share for Sun Pharmaceutical Industries Ltd. is 43.30. This figure represents the portion of a company’s profit allocated to each outstanding share of common stock, reflecting its profitability on a per-share basis.
Div Yield : The Dividend Yield for Sun Pharmaceutical Industries Ltd. is 0.74%. This ratio indicates the percentage of the company’s share price that is paid out as dividends to shareholders annually.
Book Value : The Book Value per Share for Sun Pharmaceutical Industries Ltd. is ₹265.35. This figure represents the value of the company’s net assets available to common shareholders, dividend by the number of outstanding shares.
Face Value : The Face Value per Share for Sun Pharmaceutical Industries Ltd. is 1. This is the nominal value of each share as stated on the stock certificate and does not reflect the market value of the share.

Income statement

Income Statement
Basic EPS (FY)	39.91
Basic EPS (TTM)	43.30
EPS Diluted (FY)	39.91
Net Income (FY)	95.76 B
EBITDA (TTM)	133.15 B
Gross Profit (MRQ)	68.68 B
Gross Profit (FY)	230.51 B
Last Year Revenue (FY)	478.63 B
Total Revenue (FY)	478.63 B
Free Cash Flow (TTM)	_

Financial Ratio (Last 5 Years)

Year	Operating Profit Margin	Net Profit Margin	Earning Per Share
2020	22.43%	12.75%	15.70
2021	27.80%	15.25%	12.10
2022	29.19%	17.72%	13.60
2023	27.59%	19.51%	35.30
2024	28.63%	19.89%	39.90

Shareholding Pattern

Gainers/Loosers

Penny Stocks To Buy Now

Penny Stocks Under Rs. 1

Penny Stocks Under Rs. 2

Penny Stocks Under Rs. 3

Penny Stocks Under Rs. 4

Penny Stocks Under Rs. 10

All About Indian Stock Market – BSE, NSE, SEBI, SENSEX, NIFTY 50

Disclaimer

The author and this blog do not assume any responsibility for any investment decisions made based on the information provided. Always exercise and due diligence when investing.